{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:03:33Z","timestamp":1789502613865,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31860253"],"award-info":[{"award-number":["31860253"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31971219"],"award-info":[{"award-number":["31971219"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s12032-021-01616-5","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T06:04:44Z","timestamp":1641276284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer"],"prefix":"10.1007","volume":"39","author":[{"given":"Pengfei","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingru","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aodungerile","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuewu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongju","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6142-282X","authenticated-orcid":false,"given":"Alatangaole","family":"Damirin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"key":"1616_CR1","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3390\/cancers11101523","volume":"11","author":"Y Xu","year":"2019","unstructured":"Xu Y. Targeting lysophosphatidic acid in cancer: the issues in moving from bench to bedside. Cancers. 2019;11:1523.","journal-title":"Cancers"},{"key":"1616_CR2","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.3390\/biom10091263","volume":"10","author":"X Tang","year":"2020","unstructured":"Tang X, Brindley DN. Lipid phosphate phosphatases and cancer. Biomolecules. 2020;10:1263.","journal-title":"Biomolecules"},{"key":"1616_CR3","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1158\/0008-5472.CAN-17-1624","volume":"78","author":"JH Ha","year":"2018","unstructured":"Ha JH, Radhakrishnan R, Jayaraman M, et al. LPA induces metabolic reprogramming in ovarian cancer via a pseudohypoxic response. Cancer Res. 2018;78:1923\u201334.","journal-title":"Cancer Res"},{"key":"1616_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/s12935-020-01622-z","volume":"20","author":"D Wu","year":"2020","unstructured":"Wu D, Wu F, Li B, et al. EZH2 promotes the expression of LPA1 by mediating microRNA-139 promoter methylation to accelerate the development of ovarian cancer. Cancer Cell Int. 2020;20:551.","journal-title":"Cancer Cell Int"},{"key":"1616_CR5","doi-asserted-by":"publisher","first-page":"172886","DOI":"10.1016\/j.ejphar.2019.172886","volume":"868","author":"PF Zhao","year":"2020","unstructured":"Zhao PF, Wu S, Li Y, et al. LPA receptor1 antagonists as anticancer agents suppress human lung tumours. Eur J Pharmacol. 2020;868:172886.","journal-title":"Eur J Pharmacol"},{"key":"1616_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.21037\/atm-20-1013","volume":"9","author":"W Shi","year":"2021","unstructured":"Shi W, Zhang C, Ning Z, et al. CMTM8 as an LPA1-associated partner mediates lysophosphatidic acid-induced pancreatic cancer metastasis. Ann Transl Med. 2021;9:42.","journal-title":"Ann Transl Med"},{"key":"1616_CR7","doi-asserted-by":"publisher","first-page":"109551","DOI":"10.1016\/j.cellsig.2020.109551","volume":"69","author":"N Ueda","year":"2020","unstructured":"Ueda N, Minami K, Ishimoto K, et al. Effects of lysophosphatidic acid (LPA) receptor-2 (LPA2) and LPA3 on the regulation of chemoresistance to anticancer drug in lung cancer cells. Cell Signal. 2020;69:109551.","journal-title":"Cell Signal"},{"key":"1616_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.bbrc.2020.08.087","volume":"532","author":"K Minami","year":"2020","unstructured":"Minami K, Ueda N, Ishimoto K, et al. Cooperation of G12\/13 and Gi proteins via lysophosphatidic acid receptor-2 (LPA2) signaling enhances cancer cell survival to cisplatin. Biochem Biophys Res Commun. 2020;532:427\u201332.","journal-title":"Biochem Biophys Res Commun"},{"key":"1616_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1001\/jama.280.8.719","volume":"280","author":"Y Xu","year":"1998","unstructured":"Xu Y, Shen Z, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. JAMA. 1998;280:719\u201323.","journal-title":"JAMA"},{"key":"1616_CR10","first-page":"483","volume":"6","author":"CQ Bai","year":"2014","unstructured":"Bai CQ, Yao YW, Liu CH, et al. Diagnostic and prognostic significance of lysophosphatidic acid in malignant pleural effusions. J Thorac Dis. 2014;6:483\u201390.","journal-title":"J Thorac Dis"},{"key":"1616_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1089\/gtmb.2017.0060","volume":"21","author":"R Zeng","year":"2017","unstructured":"Zeng R, Li B, Huang J, et al. Lysophosphatidic acid is a biomarker for peritoneal carcinomatosis of gastric cancer and correlates with poor prognosis. Genet Test Molr Biomark. 2017;21:641\u20138.","journal-title":"Genet Test Molr Biomark"},{"key":"1616_CR12","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA. 2020;70:7\u201330.","journal-title":"CA"},{"key":"1616_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/1878-0261.12046","volume":"11","author":"U Ray","year":"2017","unstructured":"Ray U, Chowdhury SR, Vasudevan M, et al. Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells. Mol Oncol. 2017;11:491.","journal-title":"Mol Oncol"},{"key":"1616_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cellsig.2018.01.007","volume":"44","author":"J Park","year":"2018","unstructured":"Park J, Jang JH, Oh S, et al. LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA1 and LPA2. Cell Signal. 2018;44:138.","journal-title":"Cell Signal"},{"key":"1616_CR15","doi-asserted-by":"publisher","first-page":"22331","DOI":"10.1002\/jcp.28799","volume":"234","author":"GC Li","year":"2019","unstructured":"Li GC, Qin XL, Song HH, et al. Upregulated microRNA-15b alleviates ovarian cancer through inhitbition of the PI3K\/Akt pathway by targeting LPAR3. J Cell Physiol. 2019;234:22331\u201342.","journal-title":"J Cell Physiol"},{"key":"1616_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13058-015-0538-7","volume":"17","author":"HA Azim Jr","year":"2015","unstructured":"Azim HA Jr, Peccatori FA, Brohee S, et al. RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy. Breast Cancer Res. 2015;17:24.","journal-title":"Breast Cancer Res"},{"key":"1616_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.semcancer.2019.05.012","volume":"59","author":"MK Ediriweera","year":"2019","unstructured":"Ediriweera MK, Tennekoon KH, Samarakoon SR. Role of the PI3K\/AKT\/mTOR signaling pathway in ovarian cancer: biological and therapeutic significance. Semin Cancer Biol. 2019;59:147\u201360.","journal-title":"Semin Cancer Biol"},{"key":"1616_CR18","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.2147\/CMAR.S265531","volume":"12","author":"Y Kan","year":"2020","unstructured":"Kan Y, Liu J, Li F. High expression of nuclear transcription factor-kappaB is associated with cisplatin resistance and prognosis for ovarian cancer. Cancer Manage Res. 2020;12:8241\u201352.","journal-title":"Cancer Manage Res"},{"key":"1616_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/cam4.2725","volume":"9","author":"S Kyo","year":"2020","unstructured":"Kyo S, Ishikawa N, Nakamura K, et al. The fallopian tube as origin of ovarian cancer: change of diagnostic and preventive strategies. Cancer Med. 2020;9:421\u201331.","journal-title":"Cancer Med"},{"key":"1616_CR20","doi-asserted-by":"publisher","first-page":"7547469","DOI":"10.1155\/2019\/7547469","volume":"2019","author":"H Onallah","year":"2019","unstructured":"Onallah H, Davidson B, Reich R. Diverse effects of lysophosphatidic acid receptors on ovarian cancer signaling pathways. J Oncol. 2019;2019:7547469.","journal-title":"J Oncol"},{"key":"1616_CR21","doi-asserted-by":"publisher","first-page":"144132","DOI":"10.1016\/j.gene.2019.144132","volume":"726","author":"A Soleimani","year":"2019","unstructured":"Soleimani A, Rahmani F, Ferns GA, et al. Role of the NF-\u03baB signaling pathway in the pathogenesis of colorectal cancer. Gene. 2019;726:144132.","journal-title":"Gene"},{"key":"1616_CR22","doi-asserted-by":"publisher","first-page":"117167","DOI":"10.1016\/j.lfs.2019.117167","volume":"242","author":"L Wang","year":"2019","unstructured":"Wang L, Niu Z, Wang X, et al. PHD2 exerts anti-cancer and anti-inflammatory effects in colon cancer xenografts mice via attenuating NF-\u03baB activity. Life Sci. 2019;242:117167.","journal-title":"Life Sci"},{"key":"1616_CR23","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.3390\/ijms18091903","volume":"18","author":"HC Chi","year":"2017","unstructured":"Chi HC, Tsai CY, Tsai MM, et al. Roles of long noncoding RNAs in recurrence and metastasis of radiotherapy-resistant cancer stem cells. Int J Mol Sci. 2017;18:1903.","journal-title":"Int J Mol Sci"},{"key":"1616_CR24","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/carcin\/bgx073","volume":"38","author":"D Wu","year":"2017","unstructured":"Wu D, Yang X, Peng H, et al. OCIAD2 suppressed tumor growth and invasion via AKT pathway in hepatocelluar carcinoma. Carcinogenesis. 2017;38:910\u20139.","journal-title":"Carcinogenesis"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-021-01616-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-021-01616-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-021-01616-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T04:17:46Z","timestamp":1643343466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-021-01616-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1616"],"URL":"https:\/\/doi.org\/10.1007\/s12032-021-01616-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-875460\/v1","asserted-by":"object"}]},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"assertion":[{"value":"3 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflict of interest for this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments used in this study were performed with ethical standards that the Declaration of Helsinki and national and international guidelines. This investigation was reviewed and approved by the Institutional Animal Care and Use Committee of Inner Mongolia University (Approval Number 2020001).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"17"}}